scispace - formally typeset
G

Genki Hayashi

Researcher at University of California, San Francisco

Publications -  18
Citations -  843

Genki Hayashi is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Psoriasis & Ataxia. The author has an hindex of 10, co-authored 14 publications receiving 702 citations. Previous affiliations of Genki Hayashi include University of California & University of California, Davis.

Papers
More filters
Journal ArticleDOI

Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model

TL;DR: These results support a mechanistic hypothesis in which frataxin deficiency decreases Nrf2 expression in vivo, causing the sensitivity to oxidative stress in target tissues the DRG and the cerebella, which contributes to the process of neurodegeneration.
Journal ArticleDOI

Oxidative stress in inherited mitochondrial diseases

TL;DR: The role of oxidative stress in the five most common inherited mitochondrial diseases, Friedreich ataxia, LHON, MELAS, MERRF, and Leigh syndrome, is discussed and the strongest evidence for an oxidative stress pathomechanism among the five diseases was for FriedreICH ataxian.
Journal ArticleDOI

Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans

TL;DR: It is shown that dimethyl fumarate dose-dependently induces mitochondrial biogenesis and function dosed to cells in vitro, and also dosed in vivo to mice and humans, making DMF the first drug demonstrated to increase mitochondrialBiogenesis with in vivo human dosing.
Journal ArticleDOI

Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.

TL;DR: It is found that psoriasis patients are significantly more likely than controls to have gene variants that are protective against HIV-1 disease and the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased Psoriasis susceptibility.